There were 1,876 press releases posted in the last 24 hours and 440,501 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Principia Biopharma Announces PRN1008 Receives Orphan-Drug Designation from FDA for Treatment of Immune Thrombocytopenic Purpura

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image